Whitepaper – Protecting Critical Care Drugs


Whitepaper – Protecting Critical Care Drugs

The trafficking of fake and altered drugs, including injectables, has reached epidemic levels in some parts of the word and is a growing problem in the United States. What Brand Protection security measures do you have in place to protect your brand against these counterfeit drugs?

According to the World Health Organization, 50 percent of drugs sold online are counterfeit

In this whitepaper you will learn:

  • Multi-layered solutions for positive identification
  • Importance of tracking products through the supply chain
  • Designs of a proactive, overarching anti-counterfeit strategy


Back To Top